Dose requirements and recovery profile of an infusion of cisatracurium during liver transplantation

Journal of Clinical Anesthesia

Volumn 14, Issue 2, 2002, Pages 135-139

  Cammu, Guy ^a,b   Bossuyt, Gudrun ^a   De Baerdemaeker, Luc ^a   Den Blauwen, Nadia ^a   Struys, Michel ^a   Mortier, Eric ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b OLV HOSPITAL   (Belgium)

Author keywords

Cisatracurium; Disease; Liver; Neuromuscular block; Pharmacodynamics; Pharmacokinetics; Transplantation

Indexed keywords

CISATRACURIUM;

ADULT; ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ELECTROMYOGRAPHY; FEMALE; HUMAN; INFUSION SYSTEM; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; NEUROMUSCULAR BLOCKING; PH; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ATRACURIUM; ELECTROMYOGRAPHY; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; SYNAPTIC TRANSMISSION;

EID: 0036209279     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(01)00370-1     Document Type: Article

References (14)

1. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation
2. Postoperative tracheal extubation after orthotopic liver transplantation
3. Atracurium infusion in liver transplantation
4. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure)
5. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis
6. Pharmacokinetics of atracurium and its metabolites
7. Atracurium and severe hepatic disease: A case report
8. Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anesthetized dogs
9. Pharmacokinetics/pharmacodynamics of cisatracurium in healthy adult patients
10. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1′R-cis isomer of atracurium, with atracurium besylate in healthy patients
11. The pharmacodynamics of cisatracurium in healthy adults
12. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
13. A comparison of cisatracurium and atracurium: Onset of neuromuscular block after bolus injection and recovery after subsequent infusion
14. Importance of the organ-independent elimination of cistatracurium